Literature DB >> 21086092

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.

Sarfraz Ali1, Qiqin Yin-Goen, Timothy V Johnson, Wei Han, Nicole A Johnson, Wayne B Harris, Fray F Marshall, Andrew N Young, Viraj A Master, Adeboye O Osunkoya.   

Abstract

C-reactive protein is produced in response to cytokines such as interleukin (IL)-6. It is known that increased plasma IL-6 levels induce increased hepatic and intratumoral production of C-reactive protein. Cyclooxygenase enzyme-2 is induced by various stimuli, including inflammation and various growth factors. Expression of these two markers has not been well studied in clear cell renal cell carcinoma. The objective of this study is to correlate the expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma with pathologic parameters. A search of the surgical pathology and consultation files at our institution was performed for nephrectomy specimens with clear cell renal cell carcinoma from 2007 to 2008. Immunohistochemical stains for C-reactive protein and cyclooxygenase enzyme-2 were performed. Staining intensity was graded as 0, 1+, 2+, and 3+. The staining intensity was then correlated with pathologic stage and Fuhrman nuclear grade for each case. A total of 110 cases were identified. Strong expression of C-reactive protein was associated with higher Fuhrman nuclear grade and pathologic stage, and the strength of correlation was statistically significant (p = 0.01 and p = 0.001), respectively. However, cyclooxygenase enzyme-2 expression did not show statistically significant correlation with both pathologic stage and Fuhrman nuclear grade (p = 0.1 and p = 0.15), respectively. To our knowledge, this is the largest study to date correlating the expression of both C-reactive protein and cyclooxygenase enzyme-2 in tissue with pathologic parameters in patients with clear cell renal cell carcinoma, which could have significant prognostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086092     DOI: 10.1007/s13277-010-0130-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.

Authors:  R Masunaga; H Kohno; D K Dhar; S Ohno; M Shibakita; S Kinugasa; H Yoshimura; M Tachibana; H Kubota; N Nagasue
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

3.  [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].

Authors:  Bao-dong Chang; Lin-sheng Cao; Hui-liang Zhou
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2009-09

4.  Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.

Authors:  Yoshinobu Komai; Kazutaka Saito; Kunihiko Sakai; Shinji Morimoto
Journal:  BJU Int       Date:  2006-09-06       Impact factor: 5.588

5.  Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.

Authors:  Keiichi Ito; Tomohiko Asano; Hidehiko Yoshii; Akinori Satoh; Makoto Sumitomo; Masamichi Hayakawa
Journal:  Int J Urol       Date:  2006-11       Impact factor: 3.369

Review 6.  Prognostic markers in renal cell carcinoma.

Authors:  Börje Ljungberg
Journal:  Curr Opin Urol       Date:  2007-09       Impact factor: 2.309

7.  Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.

Authors:  Yasuyoshi Miyata; Shigehiko Koga; Shigeru Kanda; Masaharu Nishikido; Tomayoshi Hayashi; Hiroshi Kanetake
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

8.  Significance of COX-2 expression in human renal cell carcinoma cell lines.

Authors:  Qinzhong Chen; Nobuo Shinohara; Takashige Abe; Takafumi Watanabe; Katsuya Nonomura; Tomohiko Koyanagi
Journal:  Int J Cancer       Date:  2004-03-01       Impact factor: 7.396

9.  C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.

Authors:  Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Claudio Jeldres; Paul Perrotte; Andrea Gallina; Jacques Tostain; Jean-Jacques Patard
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

10.  The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer.

Authors:  G W A Lamb; D C McMillan; S Ramsey; M Aitchison
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.